Michael Trettel

Array ( [id] => 3876084 [patent_doc_number] => 05728561 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-17 [patent_title] => 'Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from Streptomyces avermitilis' [patent_app_type] => 1 [patent_app_number] => 8/482385 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 17 [patent_no_of_words] => 14041 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/728/05728561.pdf [firstpage_image] =>[orig_patent_app_number] => 482385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3855194 [patent_doc_number] => 05705385 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-06 [patent_title] => 'Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer' [patent_app_type] => 1 [patent_app_number] => 8/485458 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 20 [patent_no_of_words] => 11859 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/705/05705385.pdf [firstpage_image] =>[orig_patent_app_number] => 485458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4057720 [patent_doc_number] => 05866131 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-02 [patent_title] => 'Recombinant vaccine' [patent_app_type] => 1 [patent_app_number] => 8/473301 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 22 [patent_no_of_words] => 9136 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/866/05866131.pdf [firstpage_image] =>[orig_patent_app_number] => 473301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3992730 [patent_doc_number] => 05985655 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Targetable vector particles' [patent_app_type] => 1 [patent_app_number] => 8/484126 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8027 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/985/05985655.pdf [firstpage_image] =>[orig_patent_app_number] => 484126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4062069 [patent_doc_number] => 05866410 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-02 [patent_title] => 'Cloning of the biosynthetic pathway for chlortetracycline and tetracycline formation and cosmids useful therein' [patent_app_type] => 1 [patent_app_number] => 8/474933 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 10282 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/866/05866410.pdf [firstpage_image] =>[orig_patent_app_number] => 474933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3739980 [patent_doc_number] => 05786211 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-28 [patent_title] => 'Adeno-associated virus materials and methods' [patent_app_type] => 1 [patent_app_number] => 8/475391 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5889 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/786/05786211.pdf [firstpage_image] =>[orig_patent_app_number] => 475391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3827749 [patent_doc_number] => 05739027 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-14 [patent_title] => 'MTS1E1.beta. gene' [patent_app_type] => 1 [patent_app_number] => 8/487033 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 30 [patent_no_of_words] => 36357 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/739/05739027.pdf [firstpage_image] =>[orig_patent_app_number] => 487033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3781081 [patent_doc_number] => 05821088 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-13 [patent_title] => 'Use of gram-positive bacteria to express recombinant proteins' [patent_app_type] => 1 [patent_app_number] => 8/472244 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7853 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/821/05821088.pdf [firstpage_image] =>[orig_patent_app_number] => 472244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3924515 [patent_doc_number] => 05876962 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-02 [patent_title] => 'Expression vectors for the synthesis of proteins and plasmid replicons and sequence cassettes for use in constructing such vectors' [patent_app_type] => 1 [patent_app_number] => 8/486101 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 43 [patent_no_of_words] => 18740 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/876/05876962.pdf [firstpage_image] =>[orig_patent_app_number] => 486101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3876821 [patent_doc_number] => 05747470 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-05 [patent_title] => 'Method for inhibiting cellular proliferation using antisense oligonucleotides to gp130 mRNA' [patent_app_type] => 1 [patent_app_number] => 8/484518 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5885 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/747/05747470.pdf [firstpage_image] =>[orig_patent_app_number] => 484518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3789890 [patent_doc_number] => 05780229 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Polynucleotides for determining the pen polymorphism of human platelet membrane glycoprotein IIIa' [patent_app_type] => 1 [patent_app_number] => 8/482174 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6329 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780229.pdf [firstpage_image] =>[orig_patent_app_number] => 482174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3783948 [patent_doc_number] => 05840483 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Method of maintaining a desired recombinant gene in a genetic population of cells' [patent_app_type] => 1 [patent_app_number] => 8/473926 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 19 [patent_no_of_words] => 20462 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840483.pdf [firstpage_image] =>[orig_patent_app_number] => 473926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3932536 [patent_doc_number] => 05972601 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Methods and kits for determining the pen polymorphism of human platelet membrane glycoprotein IIIA' [patent_app_type] => 1 [patent_app_number] => 8/484201 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6316 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972601.pdf [firstpage_image] =>[orig_patent_app_number] => 484201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3854618 [patent_doc_number] => 05705342 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-06 [patent_title] => 'Interaction of BCL-2 and R-RAS' [patent_app_type] => 1 [patent_app_number] => 8/484945 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 9774 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/705/05705342.pdf [firstpage_image] =>[orig_patent_app_number] => 484945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3935455 [patent_doc_number] => 05981216 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same' [patent_app_type] => 1 [patent_app_number] => 8/483813 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6760 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981216.pdf [firstpage_image] =>[orig_patent_app_number] => 483813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3884142 [patent_doc_number] => 05723292 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-03 [patent_title] => 'Stable DNA constructs' [patent_app_type] => 1 [patent_app_number] => 8/488179 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 23 [patent_no_of_words] => 15541 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/723/05723292.pdf [firstpage_image] =>[orig_patent_app_number] => 488179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3767937 [patent_doc_number] => 05849562 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Production of complementary DNA representing hepatitis A viral sequences by recombinant DNA methods and uses therefor' [patent_app_type] => 1 [patent_app_number] => 8/468926 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 27 [patent_no_of_words] => 11983 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849562.pdf [firstpage_image] =>[orig_patent_app_number] => 468926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3935427 [patent_doc_number] => 05981214 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Production of proteins using homologous recombination' [patent_app_type] => 1 [patent_app_number] => 8/467244 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 4 [patent_no_of_words] => 6063 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981214.pdf [firstpage_image] =>[orig_patent_app_number] => 467244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3723104 [patent_doc_number] => 05670149 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-23 [patent_title] => 'Lymphotoxin-.beta., Lymphotoxin-.beta. complexes, pharmaceutical preparations and therapeutic uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/476489 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 31 [patent_no_of_words] => 21898 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/670/05670149.pdf [firstpage_image] =>[orig_patent_app_number] => 476489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4355655 [patent_doc_number] => 06174685 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-16 [patent_title] => 'Human herpesvirus type 6 protein p100, the corresponding DNA sequences, their preparation and use' [patent_app_type] => 1 [patent_app_number] => 8/467528 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 2686 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/174/06174685.pdf [firstpage_image] =>[orig_patent_app_number] => 467528 [rel_patent_id] =>[rel_patent_doc_number] =>)